5-HT activates mitogen-activated protein kinase (MAPK) and the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway to promote malignant behaviors in prostate cancer cells [21] through several receptor subtypes, promoting disease progression in prostate cancer patients [11, 22]. The gene discussed is WNK2; the disease is prostate carcinoma.